Lianqing Lou
Research Subjects
Lianqing Lou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Guoqiang Ding
Yiwu Central Hospital
1 shared publication - Shuang Wu
Yiwu Central Hospital
1 shared publication - Wenjun Yang
Zhejiang University School of Medicine
1 shared publication - Xiaofei Li
Department of Infectious Diseases, YiWu Central Hospital, Zhejiang, 322000, China,
1 shared publication - Yongxin Chen
Yiwu Central Hospital
1 shared publication
Latest Publications
- 4 January 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (6) , 1099-1107
microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
MicroRNAs constitute a novel class of small, non-coding RNAs that negatively regulate gene expression via translational inhibition or mRNA degradation. Aberrant miRNA expression has been implicated in the initiation, progression, and metastasis of hepatocellular carcinoma (HCC). It is well-documented that miRNAs function as either tumor suppressor genes or oncogenes in the development and progression of HCC. Additionally, substantial evidence suggests that unique miRNA signatures can serve as valuable diagnostic and prognostic biomarkers for HCC. Interestingly, certain subsets of miRNAs have also been identified as potential therapeutic targets for HCC.
- 4 January 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (6) , 1099-1107
microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
MicroRNAs constitute a novel class of small, non-coding RNAs that negatively regulate gene expression via translational inhibition or mRNA degradation. Aberrant miRNA expression has been implicated in the initiation, progression, and metastasis of hepatocellular carcinoma (HCC). It is well-documented that miRNAs function as either tumor suppressor genes or oncogenes in the development and progression of HCC. Additionally, substantial evidence suggests that unique miRNA signatures can serve as valuable diagnostic and prognostic biomarkers for HCC. Interestingly, certain subsets of miRNAs have also been identified as potential therapeutic targets for HCC.